Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 7,294,000 | 5,135,000 | 2,422,000 | 9,530,000 | 7,361,000 |
| Depreciation Amortization | 3,251,000 | 2,154,000 | 1,194,000 | N/A | 3,570,000 |
| Income taxes - deferred | 1,230,000 | 901,000 | 417,000 | -2,166,000 | 1,214,000 |
| Other Working Capital | -3,509,000 | -4,050,000 | -2,554,000 | -165,000 | -2,954,000 |
| Other Operating Activity | 458,000 | 258,000 | 349,000 | 6,995,000 | 376,000 |
| Operating Cash Flow | $8,724,000 | $4,398,000 | $1,828,000 | $14,194,000 | $9,567,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,443,000 | 1,350,000 | 1,226,000 | -1,123,000 | 116,000 |
| PPE Investments | -1,562,000 | -894,000 | -377,000 | -2,376,000 | -1,282,000 |
| Net Acquisitions | -131,000 | -32,000 | N/A | -1,993,000 | -1,558,000 |
| Purchase Of Investment | N/A | N/A | N/A | -166,000 | N/A |
| Sale Of Investment | N/A | N/A | N/A | 220,000 | N/A |
| Purchase Sale Intangibles | -447,000 | -327,000 | -153,000 | -197,000 | -415,000 |
| Other Investing Activity | -447,000 | -327,000 | -153,000 | -237,000 | -415,000 |
| Investing Cash Flow | $-697,000 | $97,000 | $696,000 | $-5,675,000 | $-3,139,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -587,000 | -213,000 | 1,699,000 | -1,737,000 | 649,000 |
| Debt Issued | N/A | N/A | N/A | 1,979,000 | N/A |
| Debt Repayment | N/A | N/A | N/A | -704,000 | N/A |
| Common Stock Issued | N/A | N/A | N/A | 414,000 | N/A |
| Common Stock Repurchased | -526,000 | 471,000 | 1,215,000 | -511,000 | -97,000 |
| Dividend Paid | -6,100,000 | -6,100,000 | -6,106,000 | -6,116,000 | -6,030,000 |
| Other Financing Activity | -38,000 | -17,000 | -148,000 | 0 | -53,000 |
| Financing Cash Flow | $-7,251,000 | $-5,859,000 | $-3,340,000 | $-6,675,000 | $-5,531,000 |
| Exchange Rate Effect | 35,000 | -17,000 | -30,000 | -1,000 | -15,000 |
| Beginning Cash Position | 5,552,000 | 5,552,000 | 5,552,000 | 3,709,000 | 3,709,000 |
| End Cash Position | 6,363,000 | 4,077,000 | 4,706,000 | 5,552,000 | 4,591,000 |
| Net Cash Flow | $811,000 | $-1,475,000 | $-846,000 | $1,843,000 | $882,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 8,724,000 | 4,398,000 | 1,828,000 | 14,194,000 | 9,567,000 |
| Capital Expenditure | -1,855,000 | -1,096,000 | -497,000 | -2,458,000 | -1,678,000 |
| Free Cash Flow | 6,869,000 | 3,302,000 | 1,331,000 | 11,736,000 | 7,889,000 |